Endovascular revascularization in case of femoropopliteal artery occlusion
NEW TECHNOLOGIES IN MEDICINE
Abstract
Effective revascularization for patients with peripheral artery disease is much more than an elementary procedure. The approach to the patient with symptom-limiting intermittent claudication or limb-threatening ischemia begins with understanding the population at risk and variation in clinical presentation. The urgency of revascularization varies significantly by presentation; from patients with intermittent claudication who should undergo structured exercise rehabilitation before revascularization (if needed) to those with acute limb ischemia, a medical emergency, who require revascularization within hours. Recent years have seen the rapid development of new tools including wires, catheters, drug-eluting technology, specialized balloons, and biomimetic stents. Open surgical bypass remains an important option for those with advanced disease. The strategy and techniques employed vary by clinical presentation, lesion location, and lesion severity. There is limited level 1 evidence to guide practice, but factors that determine technical success and anatomic durability are largely understood and incorporated into decision-making. Following revascularization, medical therapy to reduce adverse limb outcomes and a surveillance plan should be put in place. There are many hurdles to overcome to improve the efficacy of lower extremity revascularization, such as restenosis, calcification, microvascular disease, silent embolization, and tools for perfusion assessment. Endovascular revascularization is a critical strategy in managing total occlusions of the femoropopliteal artery, a significant challenge in patients with peripheral artery disease. This review provides a comprehensive analysis of procedural strategies, highlighting the role of drug-coated balloons, atherectomy devices, and advanced crossing techniques like subintimal recanalization and re-entry methods. It discusses the importance of lesion-specific considerations, such as the use of atherectomy devices for un-crossable or un-dilatable lesions and the effectiveness of drug-coated balloons in reducing restenosis. Emerging techniques, including the PIERCE needle-cracking method and intravascular lithotripsy, offer novel approaches for treating heavily calcified plaques. Moreover, the review compares endovascular interventions with surgical bypass, noting that while minimally invasive techniques are preferred for high-risk patients, a hybrid approach may be optimal for selected cases. Despite advances, challenges remain regarding long-term outcomes and the management of complex calcified lesions, emphasizing the need for ongoing research and innovation in this field.
References
1. Aboyans V., Ricco J.B., Bartelink M.L., Bjorck M., Brodmann M., Cohner T., Pieniazek P. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Kardiol Pol. 2017;75:1065–1160. https://doi.org/10.1093/eurheartj/ehx095
2. Gerhard-Herman M.D., Gornik H.L., Barrett C., Barshes N.R., Corriere M.A., Drachman D.E. et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(12):e726–e779. https://doi.org/10.1161/CIR.0000000000000471.
3. Herten M., Torsello G.B., Schonefeld E., Imm B., Osada N., Stahlhoff S. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis. J Vasc Surg. 2015;61(2):394–399. https://doi.org/10.1016/j.jvs.2014.08.005.
4. Zeller T., Rastan A., Macharzina R., Tepe G., Kaspar M., Chavarria J. et al. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. J Endovasc Ther 2014;21(3):359–368. https://doi.org/10.1583/13-4630MR.1.
5. Virga V., Stabile E., Biamino G., Salemme L., Cioppa A., Giugliano G., Rubino P. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up. JACC Cardiovasc Interv. 2014;7(4):411–415. https://doi.org/10.1016/j.jcin.2013.11.020.
6. Fanelli F., Cannavale A., Gazzetti M., Lucatelli P., Wlderk A., Cirelli C., D’adamo A., Salvatori F.M. Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. Cardiovasc Interv Radiol. 2014;37(4):898–907.
7. Zeller T., Langhoff R., Rocha-Singh K.J., Jaff M.R., Blessing E., Amann-Vesti B., Tepe G. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study. Circ Cardiovasc Interv. 2017;10(9):e004848. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004848.
8. Dattilo R., Himmelstein S.I., Cuff R.F. The COMPLIANCE 360 degrees Trial: A randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. J Invasive Cardiol. 2014;26(8):355–360.
9. Tepe G., Brodmann M., Werner M., Bachinsky W., Holden A., Zeller T. et al. Intravascular lithotripsy for peripheral artery calcification: 30-day outcomes from the randomized disrupt PAD III trial. JACC Cardiovasc Interv. 2021;14(12):1352–1361. https://doi.org/10.1016/j.jcin.2021.04.010.
10. Nice C., Timmons G., Bartholemew P., Uberoi R. Retrograde vs. antegrade puncture for infra-inguinal angioplasty. Cardiovasc Interv Radiol. 2003;26(4):370–374. https://doi.org/10.1007/s00270-003-2721-y.
11. Cragg J., Lowry D., Hopkins J., Parker D., Kay M., Duddy M., Tiwari A. Safety and outcomes of ipsilateral antegrade angioplasty for femoropopliteal disease. Vasc Endovas. Surg. 2018;52(2):93–97. https://doi.org/10.1177/1538574417739762.
12. Ishihara T., Takahara M., Iida O., Soga Y., Hirano K., Yamauchi Y. et al. Comparable 2-year restenosis rates following subintimal and intraluminal drug-eluting stent implantation for femoropopliteal chronic total occlusion. J Endovasc Ther. 2016;23(6):889–895. https://doi.org/10.1177/1526602816666261.
13. Soga Y., Iida O., Suzuki K., Hirano K., Kawasaki D., Shintani Y., Suematsu N., Yamaoka T. Initial and 3-year results after subintimal versus intraluminal approach for long femoropopliteal occlusion treated with a self-expandable nitinol stent. J Vasc Surg. 2013;58(6):1547–1555. https://doi.org/10.1016/j.jvs.2013.05.107.
14. Solimeno G., Salcuni M., Capparelli G., Valitutti P. Technical perspectives in the management of complex infrainguinal arterial chronic total occlusions. J Vasc Surg. 2022;75(2):732–739. https://doi.org/10.1016/j.jvs.2021.09.022.
15. Giusca S., Lichtenberg M., Hagstotz S., Eisenbach C., Katus H.A., Erbel C., Korosoglou G. Comparison of ante-versus retrograde access for the endovascular treatment of long and calcified, de novo femoropopliteal occlusive lesions. Heart Vessel. 2020;35(3):346–359. https://doi.org/10.1007/s00380-019-01498-8.
16. Kitrou P., Parthipun A., Diamantopoulos A., Paraskevopoulos I., Karunanithy N., Katsanos K. Targeted true lumen re-entry with the outback catheter: accuracy, success, and complications in 100 peripheral chronic total occlusions and systematic review of the literature. J Endovasc Ther. 2015;22(4):538–545. https://doi.org/10.1177/1526602815594249.
17. Giannopoulos S., Palena L.M., Armstrong E.J. Technical success and complication rates of retrograde arterial access for endovascular therapy for critical limb ischaemia: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2021;61(2):270–279. https://doi.org/10.1016/j.ejvs.2020.11.020.
18. Zorger N., Manke C., Lenhart M., Finkenzeller T., Djavidani B., Feuerbach S., Link J. Peripheral arterial balloon angioplasty: effect of short versus long balloon inflation times on the morphologic results. J Vasc Interv Radiol. 2002;13(4):355–359. https://doi.org/10.1016/s1051-0443(07)61736-9.
19. Caradu C., Lakhlifi E., Colacchio E.C., Midy D., Bérard X., Poirier M., Ducasse E. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease. J Vasc Surg. 2019;70(3):981–995.e10. https://doi.org/10.1016/j.jvs.2019.01.080.
20. Shirai S., Mori S., Yamaguchi K., Mizusawa M., Chishiki T., Makino K. et al. Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion. CVIR Endovasc. 2022;5(1):46. https://doi.org/10.1186/s42155-022-00324-z.
21. Koeckerling D., Raguindin P.F., Kastrati L., Bernhard S., Barker J., Centeno A.C.Q. et al. Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: A meta-analysis. Eur Heart J. 2023;44(11):935–950. https://doi.org/10.1093/eurheartj/ehac722.
22. Liistro F., Angioli P., Porto I., Ducci K., Falsini G., Ventoruzzo G., Bolognese L. Drug-eluting balloon versus drug-eluting stent for complex femoropopliteal arterial lesions: the DRASTICO study. J Am Coll Cardiol. 2019;74(2):205–215. https://doi.org/10.1016/j.jacc.2019.04.057.
23. Gouëffic Y., Sauguet A., Desgranges P., Feugier P., Rosset E., Ducasse E. et al. A polymer-free paclitaxel-eluting stent versus a bare-metal stent for de novo femoropopliteal lesions: the BATTLE trial. JACC Cardiovasc Interv. 2020;13(4):447–457. https://doi.org/10.1016/j.jcin.2019.12.028.
24. Gray W.A., Keirse K., Soga Y., Benko A., Babaev A., Yokoi Y. et al. A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): A randomised, non-inferiority trial. Lancet. 2018;392(10157):1541–1551. https://doi.org/10.1016/S0140-6736(18)32262-1.
25. Ichihashi S., Sato T., Iwakoshi S., Itoh H., Kichikawa K. Technique of percutaneous direct needle puncture of calcified plaque in the superficial femoral artery or tibial artery to facilitate balloon catheter passage and balloon dilation of calcified lesions. J Vasc Interv Radiol. 2014;25(5):784–788. https://doi.org/10.1016/j.jvir.2014.01.016.
26. Gray W.A., Garcia L.A., Amin A., Shammas N.W., JET Registry Investigators. Jetstream Atherectomy System treatment of femoropopliteal arteries: Results of the post-market JET Registry. Cardiovasc Revasc Med. 2018;19(5 Pt A):506–511. https://doi.org/10.1016/j.carrev.2017.12.015.
27. Giannakopoulos N.N., Ariaans K., Eberhard L., Klotz A., Oh K., Kappel S. Immediate and delayed loading of two-piece reduced-diameter implants with locator-analog attachments in edentulous mandibles: One-year results from a randomized clinical trial examining clinical outcome and patient expectation. Clin Implant Dent Relat Res. 2017;19(4):643–653. https://doi.org/10.1111/cid.12489.
28. Beucler A., Wheibe E., Gandhi S.S., Blas J.V., Carsten C.G., 3rd, Gray B.H. Outcomes of endovascular treatment for critical limb threatening ischemia. Ann Vasc Surg. 2024;99:434–441. https://doi.org/10.1016/j.avsg.2023.09.077.
29. Abouzid M.R., Vyas A., Kamel I., Anwar J., Elshafei S., Subramaniam V. et al. Comparing the efficacy and safety of endovascular therapy versus surgical revascularization for critical limb-threatening ischemia: A systematic review and meta-analysis. Prog Cardiovasc Dis. 2025;88:126–135. https://doi.org/10.1016/j.pcad.2024.06.008.
30. Adam D.J., Beard J.D., Cleveland T., Bell J., Bradbury A.W., Forbes J.F. et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925–1934. https://doi.org/10.1016/S0140-6736(05)67704-5.
31. Farber A., Menard M.T., Conte M.S., Kaufman J.A., Powell R.J., Choudhry N.K. et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med. 2022;387(25):2305–2316. https://doi.org/10.1056/NEJMoa2207899.
32. Bradbury A.W., A Moakes C., Popplewell M., Meecham L., Bate G.R., Kelly L. et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): An open-label, randomised, multicentre, phase 3 trial. Lancet. 2023;401(10390):1798–1809. https://doi.org/10.1016/S0140-6736(23)00462-2.
33. Murakami A. Hybrid operations in patients with peripheral arterial disease. Ann Vasc Dis. 2018;11(1):57–65. https://doi.org/10.3400/avd.ra.18-00006.
34. Kuchay A.A., Lipin A.N., Gruzdev N.N., Borisov A.G., Shiran V.A., Kurach M. Lower extremity peripheral artery disease: contemporary epidemiology, management and future trends (a scientific statement). Russian Biomedical Research. 2023;8(4):54–64. (In Russ.). https://doi.org/10.56871/RBR.2023.32.30.007.
35. Kuchay A.A., Lipin A.N., Padaria Sh.F. et al. Chronic limb threatening ischemia — epidemiology, pathogenesis, diagnosis and treatment strategies. Russian Biomedical Research. 2024;9(3):53–61. (In Russ.). https://doi.org/10.56871/RBR.2024.95.99.007.
36. Kuchay A.A., Lipin A.N., Antropov A.V. et al. Revascularization of patients with multilevel artery lesions of the lower limbs. Angiology and Vascular Surgery. Journal of Academician A.V. Pokrovsky. 2023;29(S2):176–177. (In Russ.).
37. Kuchay A.A., Lipin A.N., Antropov A.V. et al. Evaluation of effectiveness of the application of hybrid operative interventions in the treatment of patients with multi-story artery lesions of the lower limbs in critical limb ischemia. Angiology and Vascular Surgery. Journal of Academician A.V. Pokrovsky. 2023;29(S2):177–179. (In Russ.).
38. Kuchay A.A., Lipin A.N., Gruzdev N.N. et al. Comparison of clinical outcome of bypass surgery versus below the knee angioplasty and stenting in infrapopliteal lesions that results in ulcer or toe gangrene. Russian Biomedical Research. 2024;9(2):50–56. (In Russ.). https://doi.org/10.56871/RBR.2024.50.12.006.
39. Kuchay A.A., Lipin A.N., Kurianov P.S., Gruzdev N.N., Atmatzas K.A., Karelina N.R., Artyuh L.Y. The hybrid surgery concepts for atherosclerotic lesions of lower limb arteries. Atherosclerosis and dyslipidemias. 2023;52(3):37–43. (In Russ.). https://doi.org/10.34687/2219-8202.JAD.2023.03.0005.
40. Kuchay A.A., Lipin A.N. Hybrid interventions on distal sections of the main arteries in extended chronic occlusions of the superficial femoral artery in patients with critical limb ischemia. Atherosclerosis and dyslipidemias. 2024;55(2):33–40. (In Russ.). https://doi.org/10.34687/2219-8202.JAD.2024.02.0004.
41. Kuchay A.A., Lipin A.N., Antropov A.V. et al. Conception of “distal hybrid” for extended occlusions of the superficial femoral artery with severe lesions of outflow in critical limb ischemia. Angiology and Vascular Surgery. Journal of Academician A.V. Pokrovsky. 2022;28(S1):157–161. (In Russ.).
42. Kuchay A.A., Lipin A.N., Antropov A.V. et al. Modern concepts and principles of treatment for extended occlusions of the superficial femoral artery with severe lesions of the tibial arteries in critical limb ischemia. Angiology and Vascular Surgery. Journal of Academician A.V. Pokrovsky. 2023;29(S2):179–180. (In Russ.).
43. Kuchay A.A., Lipin A.N., Kurianov P.S. et al. Distal hybrids for long total occlusion of superficial femoral artery with severely compromised runoff. Journal of Vascular and Endovascular Therapy. 2019;4(S):52–53. (In Russ.).
44. Kuchay A.A., Lipin A.N. A comparative retrospective analysis of the results of hybrid interventions and femoral-tibial bypass in extended multi-level infrainguinal arterial segment lesions in patients with chronic critical limb ischemia. Pediatrician (St. Petersburg). 2023;14(6):25–35. (In Russ.). https://doi.org/10.17816/PED626430
45. Kuchay A.A., Lipin A.N., Kurianov P.S. Advantages of the hybrid revascularization technique in the treatment of extended occlusions of the superficial femoral artery and multilevel lesions of the lower extremity arteries. Regional Hemodynamics and Microcirculation. 2024;23(2):60–66. (In Russ.). https://doi.org/10.24884/1682-6655-2024-23-2-60-66.
46. Kuchay A.A., Lipin A.N., Antropov A.V. et al.Hybrid approach in treatment of extended occlusions of arteries of the lower limbs in CLI. Angiology and Vascular Surgery. Journal of Academician A.V. Pokrovsky. 2019;25(S2):260–264. (In Russ.).
47. Kuchay A.A., Lipin A.N., Antropov A.V. et al. Treatment of multi-level arterial lesions of lower limb arteries in CLI. Angiology and Vascular Surgery. Journal of Academician A.V. Pokrovsky. 2021;27(S2):410–412. (In Russ.).
48. Kuchay A.A., Lipin A.N., Antropov A.V. et al. Hybrid approach to extended occlusions of SFA in CLI. Angiology and Vascular Surgery. Journal of Academician A.V. Pokrovsky. 2022;28(S1):161–163. (In Russ.).
49. Kuchay A.A., Lipin A.N., Gruzdev N.N. et al. Critical limb threatening ischemia and its management. Russian Biomedical Research. 2024;9(1):34–47. (In Russ.). https://doi.org/10.56871/RBR.2024.68.81.005.
50. Kuchay A.A., Lipin A.N. Modern concept and revascularization of extended occlusion of the superficial femoral artery accompanied by multilevel occlusions of the lower extremities in chronic limb threatening ischemia. Journal Modern Science: Actual Problems of Theory and Practice: Series: Natural and Technical Sciences. 2025;10:(259–263). (In Russ.). https://doi.org/10.37882/2223-2966.2025.10.23.
51. Borisov A.G., Atmadzas K.A., Gruzdev N.N. et al. Comparison of the results of autovenous bypass operations on the anterior tibial artery depending on the choice of access. Surgery. Journal named after N.I. Pirogov. 2025;(7):5–10. (In Russ.). https://doi.org/10.17116/hirurgia20250715.
52. Borisov A.G., Atmatzas K.A., Gruzdev N.N. et al. Tibial autovenous bypass with single-segment and spliced vein. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;18(5):534–538. (In Russ.). https://doi.org/10.17116/kardio202518051534.
53. Kuchay A.A., Lipin A.N. In-hospital and mid-term results of implementing the hybrid surgical technique for extended occlusion of the superficial femoral artery in combination with the lesion of crural arteries in chronic limb threatening ischemia. Journal Modern Science: Actual Problems of Theory and Practice. Series: Natural and Technical Sciences. 2025;(12):229–236. (In Russ.). https://doi.org/10.37882/2223-2966.2025.12.22.
54. Kuchay A.A., Lipin A.N., Kozlov K.L., Gruzdev N.N., Dimov I.D., Borisov A.G. The importance and principles of endovascular technologies and “hybrid approaches” in the treatment of occlusive lesions of lower extremity arteries. Russian Biomedical Research. 2025;10(4):125–139. (In Russ.). https://doi.org/10.56871/RBR.2025.29.66.009.
This work is licensed under a Creative Commons Attribution 4.0 International License.
